Your session is about to expire
← Back to Search
Mobile Application
Learn to Quit-HIV for Tobacco Use Disorder
N/A
Waitlist Available
Led By Lauren Pacek, PhD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 18 years or older
Current interest in quitting smoking
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
This study is evaluating whether an app can help individuals with HIV quit smoking.
Eligible Conditions
- Tobacco Use Disorder
- HIV/AIDS
- Smoking Cessation
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
App Usability as Measured by the Systems Usability Scale
Duration of Daily App Use
Frequency of App Use as Measured by Interactions Per Day
+4 moreSecondary outcome measures
7-day Point Prevalence Abstinence
Number of Participants With at Least One Adverse Event Determined to be Related to the Study Interventions
Number of Quit Attempts
+2 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Learn to Quit-HIVExperimental Treatment3 Interventions
A smartphone app developed by the research team designed for people with HIV that provides Acceptance and Commitment Therapy skills to address smoking cessation. This app intervention is combined with an 8-week course of nicotine replacement therapy (NRT) patches, along with technical smartphone coaching for the first 4 weeks of the study.
Group II: QuitGuideActive Control3 Interventions
A smartphone app developed by the National Cancer Institute which uses smoking cessation recommendations contained in the US DHHS (United States Department of Health and Human Services) Clinical Practice Guidelines. This app intervention is combined with an 8-week course of nicotine replacement therapy (NRT) patches, along with technical smartphone coaching for the first 4 weeks of the study.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Learn to Quit-HIV
2021
N/A
~60
Smartphone coaching
2021
N/A
~60
Nicotine patch
2015
Completed Phase 4
~7450
Find a Location
Who is running the clinical trial?
Duke UniversityLead Sponsor
2,351 Previous Clinical Trials
3,407,783 Total Patients Enrolled
28 Trials studying Tobacco Use Disorder
5,157 Patients Enrolled for Tobacco Use Disorder
National Institutes of Health (NIH)NIH
2,682 Previous Clinical Trials
6,930,747 Total Patients Enrolled
45 Trials studying Tobacco Use Disorder
26,169 Patients Enrolled for Tobacco Use Disorder
Lauren Pacek, PhDPrincipal InvestigatorDuke University
1 Previous Clinical Trials
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger